furosemide and amiodarone

furosemide has been researched along with amiodarone in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (7.69)	18.7374
1990's	3 (7.69)	18.2507
2000's	10 (25.64)	29.6817
2010's	23 (58.97)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Gozalbes, R; Pineda-Lucena, A	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Barlow, JW; Lim, CF; Raggatt, LE; Stockigt, JR; Topliss, DJ	1
Cramarossa, L; D'Angelo, D; Galassi, A; Puletti, M	1
Hamblin, PS; Kolliniatis, E; Lim, CF; Stockigt, JR; Topliss, DJ	1
D'Arcy, PF	1
Barlow, JW; Curtis, AJ; Loidl, NM; Raggatt, LE; Stockigt, JR; Topliss, DJ	1
Charloux, A; Epailly, E; Frans, A; Lampert, E; Lonsdorfer, J; Mettauer, B; Oswald, M; Piquard, F; Zhao, QM	1
Chenzbraun, AI; Kharash, LM	1
Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA	1
Albajar-Viñas, P; Gimena, B; González-Mediero, G; Martínez-Vázquez, C; Román, F; Sopeña, B; Sousa, J	1
Andelfinger, G; Cadrin-Tourigny, J; Fournier, A; Khairy, P	1
Hayashi, T; Hosoda, K; Matsuo, M; Miyazaki, A; Sakaguchi, H; Tsuda, E	1
Barberá, M; Marchante, M; Navarro, JL; Ramos, F; Vicente, R	1
Csabai, K; Fenyvesi, É; Malanga, M; Szemán, J; Szente, L	1
Dadarkar, SS; Gatne, MM; Husain, R; Karande, VV; Kauthale, RR	1
Hu, J; Li, J; Xia, Z; Yan, S; Yu, J; Zhu, B	1
Delafontaine, P; Deo, R; Doerfler, RM; Fink, JC; Fischer, MJ; Jaar, BG; Kramlik, S; Makos, GK; Navaneethan, S; Ojo, A; Slaven, A; Snitker, S; Soliman, EZ; St Peter, WL; Weir, MR; Zhan, M	1
Fernandes, FM; Martins, RR; Oliveira, AG; Silva, EP	1

Reviews

2 review(s) available for furosemide and amiodarone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Drugs and the thyroid gland]. La Clinica terapeutica, 1987, Nov-30, Volume: 123, Issue:4 Topics: Adrenergic beta-Antagonists; Amiodarone; Carbamazepine; Danazol; Drug-Related Side Effects and Adverse Reactions; Furosemide; Humans; Lithium; Phenylacetates; Phenytoin; Thyroid Gland	1987

Other Studies

37 other study(ies) available for furosemide and amiodarone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Characterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferases. Thyroid : official journal of the American Thyroid Association, 1992,Spring, Volume: 2, Issue:1 Topics: Amiodarone; Animals; Binding Sites; Binding, Competitive; Cytosol; Diclofenac; Dithiothreitol; Dose-Response Relationship, Drug; Durapatite; Furosemide; Glutathione Transferase; Hydrocortisone; Hydroxyapatites; In Vitro Techniques; Iopanoic Acid; Liver; Macaca fascicularis; Mefenamic Acid; Sulfobromophthalein; Taurocholic Acid; Triiodothyronine	1992
Furosemide, fenclofenac, diclofenac, mefenamic acid and meclofenamic acid inhibit specific T3 binding in isolated rat hepatic nuclei. Journal of endocrinological investigation, 1988, Volume: 11, Issue:5 Topics: Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Diclofenac; Furosemide; In Vitro Techniques; Liver; Male; Meclofenamic Acid; Mefenamic Acid; Phenylacetates; Phenytoin; Rats; Rats, Inbred Strains; Receptors, Thyroid Hormone	1988
Early reports on drug interactions. Drug intelligence & clinical pharmacy, 1983, Volume: 17, Issue:2 Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine	1983
Drug competition for intracellular triiodothyronine-binding sites. European journal of endocrinology, 1994, Volume: 130, Issue:4 Topics: Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Binding, Competitive; Carcinoma, Hepatocellular; Fatty Acids, Nonesterified; Flavonoids; Furosemide; Humans; Iodide Peroxidase; Liver; Liver Neoplasms; Macaca fascicularis; Sex Hormone-Binding Globulin; Sulfobromophthalein; Triiodothyronine; Tumor Cells, Cultured	1994
Lung membrane diffusing capacity, heart failure, and heart transplantation. The American journal of cardiology, 1999, Jan-01, Volume: 83, Issue:1 Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Carbon Monoxide; Case-Control Studies; Cytomegalovirus Infections; Diuretics; Female; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Linear Models; Male; Middle Aged; Pulmonary Diffusing Capacity; Respiratory Function Tests; Smoking; Time Factors	1999
[Pacemaker syndrome in the absence of artificial pacemaker (pseudopacemaker syndrome)]. Terapevticheskii arkhiv, 2004, Volume: 76, Issue:6 Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Diagnosis, Differential; Echocardiography; Edema; Electrocardiography; Furosemide; Heart Conduction System; Heart Rate; Humans; Male; Syndrome; Treatment Outcome; Ventricular Function, Left	2004
Compatibility of argatroban with selected cardiovascular agents. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Nov-15, Volume: 61, Issue:22 Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins	2004
[Chest pain and peripheral eosinophilia]. Revista clinica espanola, 2007, Volume: 207, Issue:2 Topics: Adult; Amiodarone; Chagas Cardiomyopathy; Chest Pain; Diuretics; Drug Therapy, Combination; Electrocardiography; Eosinophilia; Furosemide; Humans; Male; Nitroimidazoles; Radiography, Thoracic; Trypanocidal Agents; Vasodilator Agents	2007
Severe left ventricular dysfunction in infants with ventricular preexcitation. Heart rhythm, 2008, Volume: 5, Issue:9 Topics: Adrenergic alpha-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Diuretics; Female; Furosemide; Humans; Infant; Propanolamines; Risk Factors; Ventricular Dysfunction, Left; Ventricular Premature Complexes; Wolff-Parkinson-White Syndrome	2008
Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood. Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1 Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Natriuretic Peptide, Brain; Propanolamines; Recurrence; Spironolactone; Vasodilator Agents; Ventricular Dysfunction, Left	2010
[Postoperative management of postpneumonectomy pulmonary edema in a patient with ostium secundum atrial septal defect]. Revista espanola de anestesiologia y reanimacion, 2011, Volume: 58, Issue:4 Topics: Adenocarcinoma; Amiodarone; Bundle-Branch Block; Combined Modality Therapy; Diuretics; Electric Countershock; Emergencies; Female; Furosemide; Heart Septal Defects, Atrial; Humans; Hypertension, Pulmonary; Lung Neoplasms; Middle Aged; Pneumonectomy; Postoperative Complications; Pulmonary Edema; Respiration, Artificial; Respiratory Insufficiency; Smoking; Ultrasonography	2011
Methyl-beta-cyclodextrins: the role of number and types of substituents in solubilizing power. Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:5 Topics: Amiodarone; beta-Cyclodextrins; Cholesterol; Chromatography, High Pressure Liquid; Fatty Acids; Furosemide; Isomerism; Magnetic Resonance Spectroscopy; Methylation; Solubility; Tamoxifen	2014
Assessment of temperature-induced hERG channel blockade variation by drugs. Journal of applied toxicology : JAT, 2015, Volume: 35, Issue:7 Topics: Albendazole; Amiodarone; Animals; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Enrofloxacin; Estradiol; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Furosemide; Gentamicins; Ivermectin; Patch-Clamp Techniques; Potassium Channel Blockers; Temperature; Xylazine	2015
A rare form of extremely wide QRS complex due to reversed homologous electrical ventricular separation of acute heart failure. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2018, Volume: 23, Issue:1 Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzazepines; Diuretics; Electric Countershock; Electrocardiography; Furosemide; Heart Failure; Heart Valve Diseases; Heart Ventricles; Humans; Male; Metoprolol; Middle Aged; Pacemaker, Artificial; Spironolactone; Tachycardia, Ventricular	2018
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. Clinical journal of the American Society of Nephrology : CJASN, 2017, 09-07, Volume: 12, Issue:9 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Citalopram; Diabetes Complications; Diuretics; Electrocardiography; Female; Fluoxetine; Furosemide; Heart; Heart Rate; Histamine H1 Antagonists; Humans; Hydroxyzine; Male; Metolazone; Middle Aged; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Venlafaxine Hydrochloride	2017
QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications. PloS one, 2018, Volume: 13, Issue:6 Topics: Adult; Aged; Amiodarone; Clopidogrel; Critical Illness; Cross-Sectional Studies; Electrocardiography; Female; Furosemide; Haloperidol; Humans; Intensive Care Units; Long QT Syndrome; Male; Middle Aged; Odds Ratio; Prevalence; Prospective Studies; Risk Factors	2018